뒤로
Zhaoke Ophthalmology Limited(06622.HK) 가격
06622.HK 주가 차트
ZHAOKE OPHTH-B (06622.HK)
Zhaoke Ophthalmology Limited
HK$3.4
0.59%
$0.02
정규장: Jan 20, 11:22:16 HKT
아직 데이터 없음Earnings FAQ
06622.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Zhaoke Ophthalmology Limited 06622.HK의 지난 분기 매출 실적은 어땠나요?
Zhaoke Ophthalmology Limited의 매출 추정치는 얼마인가요?
Zhaoke Ophthalmology Limited의 수익 품질 점수는 얼마인가요?
Zhaoke Ophthalmology Limited는 언제 수익을 보고하나요?
Zhaoke Ophthalmology Limited의 예상 수익은 얼마인가요?
Zhaoke Ophthalmology Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$3.4
시가
$3.38
일일 범위
$3.36 - $3.48
52주 범위
$1.26 - $4.6
거래량
182.5K
평균 거래량
1.0M
EPS(TTM)
-0.56
배당수익률
--
시가총액
$1.8B
ZHAOKE OPHTH-B란 무엇인가요?
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. The company is headquartered in Guangzhou, Guangdong and currently employs 270 full-time employees. The company went IPO on 2021-04-29. The product pipelines primarily include NVK002 (Atropine) for myopia, CsA Ophthalmic Gel for DED and TAB014 (Bevacizumab) for wAMD. The products are primarily uses to treat eye diseases across both the front and the back of the eye, including dry eye disease (DED), myopia, presbyopia, wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), glaucoma and corneal epithelial dysfunction (CED). The firm conducts its business in the domestic market and overseas markets.